{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:17:21Z","timestamp":1778570241849,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["11758"],"award-info":[{"award-number":["11758"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejca.2026.116673","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:41:55Z","timestamp":1774021315000},"page":"116673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Toremifene in desmoid fibromatosis: Prospective phase 2 study of two dose levels"],"prefix":"10.1016","volume":"239","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8031-5528","authenticated-orcid":false,"given":"Chiara","family":"Colombo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1762-1375","authenticated-orcid":false,"given":"Gabriele","family":"Tin\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Palassini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonino","family":"Belfiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Marrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6158-210X","authenticated-orcid":false,"given":"Paola","family":"Collini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8220-424X","authenticated-orcid":false,"given":"Marco","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Radaelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alba","family":"Miceli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Gronchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2026.116673_bib1","doi-asserted-by":"crossref","first-page":"7690","DOI":"10.1158\/0008-5472.CAN-10-1656","article-title":"Aggressive fibromatosis (desmoid tumor) is derived from mesenchymal progenitor cells","volume":"70","author":"Wu","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2026.116673_bib2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/gcc.22272","article-title":"Near universal detection of alterations in CTNNB1 and wnt pathway regulators in desmoid-type fibro- matosis by whole-exome sequencing and genomic analysis","volume":"54","author":"Crago","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"10.1016\/j.ejca.2026.116673_bib3","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/jamaoncol.2024.1805","article-title":"Desmoid Tumor Working Group. Current management of desmoid tumors: a review","volume":"10","author":"Kasper","year":"2024","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2026.116673_bib4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1158\/1078-0432.CCR-24-2340","article-title":"Active surveillance in patients with extra-abdominal desmoid-type fibromatosis: a pooled analysis of three prospective observational studies","volume":"31","author":"Colombo","year":"2025","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2026.116673_bib5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejca.2020.10.035","article-title":"CRYODESMO-O1: a prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment","volume":"143","author":"Kurtz","year":"2021","journal-title":"Eur J Cancer"},{"issue":"20","key":"10.1016\/j.ejca.2026.116673_bib6","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.3390\/cancers14205045","article-title":"Selective intra-arterial doxorubicin eluting microsphere embolization for desmoid fibromatosis: a combined prospective and retrospective study","volume":"14","author":"Elnekave","year":"2022","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.ejca.2026.116673_bib7","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/pbc.24457","article-title":"Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: results of a Children's Oncology Group (COG) phase II study","volume":"60","author":"Skapek","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2026.116673_bib8","first-page":"125","article-title":"Clinical outcome of tamoxifen and sulindac for desmoid tumors in adults: a phase II single institution experience","volume":"10","author":"Anter","year":"2019","journal-title":"Middle East J Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2026.116673_bib9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.soc.2016.05.010","article-title":"Desmoid-type fibromatosis: evolving treatment standards","volume":"25","author":"Fiore","year":"2016","journal-title":"Surg Oncol Clin N Am"},{"issue":"25","key":"10.1016\/j.ejca.2026.116673_bib10","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa1805052","article-title":"Sorafenib for advanced and refractory desmoid tumors","volume":"379","author":"Gounder","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ejca.2026.116673_bib11","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJMoa2210140","article-title":"Nirogacestat, a gamma-secretase inhibitor for desmoid tumors","volume":"388","author":"Gounder","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2026.116673_bib12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejca.2019.11.013","article-title":"The management of desmoid tumours: a joint global consensus-based guideline approach for adult and paediatric patients","volume":"127","author":"Tumor","year":"2020","journal-title":"Eur J Cancer"},{"issue":"6-7","key":"10.1016\/j.ejca.2026.116673_bib13","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/0959-8049(92)90445-8","article-title":"Desmoid tumours treated with triphenylethylenes","volume":"28A","author":"Brooks","year":"1992","journal-title":"Eur J Cancer"},{"issue":"18","key":"10.1016\/j.ejca.2026.116673_bib14","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.ejca.2015.08.026","article-title":"Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosis","volume":"51","author":"Fiore","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.116673_bib15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2026.116673_bib16","first-page":"1079","article-title":"There are no bad anticancer agents, only bad clinical trial designs\u2014twenty-first Richard and Hinda Rosenthal Foundation Award Lecture","volume":"4","author":"Von Hoff","year":"1998","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.ejca.2026.116673_bib17","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/cncr.21553","article-title":"Estrogen receptor-beta expression in extra-abdominal fibromatoses: an analysis of 40 cases","volume":"106","author":"Deyrup","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2026.116673_bib18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.yexcr.2003.09.029","article-title":"Growth factors regulate \u03b2-catenin-mediated TCF-dependent transcriptional activation in fibroblasts during the proliferative phase of wound healing","volume":"293","author":"Cheon","year":"2004","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.ejca.2026.116673_bib19","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0002-9610(05)80797-4","article-title":"Growth factors and wound healing; biochemical properties of growth factors and their receptors","volume":"165","author":"Bennet","year":"1993","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejca.2026.116673_bib20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/SLA.0b013e31828c8a30","article-title":"A prognostic nomogram for prediction of recurrence in desmoid fibromatosis","volume":"258","author":"Crago","year":"2013","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.ejca.2026.116673_bib21","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1463-1318.2011.02758.x","article-title":"Anti-oestrogen therapy in the treatment of desmoid tumours: a systematic review","volume":"13","author":"Bocale","year":"2011","journal-title":"Colorectal Dis"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926004533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926004533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:53:30Z","timestamp":1778568810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926004533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":21,"alternative-id":["S0959804926004533"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116673","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toremifene in desmoid fibromatosis: Prospective phase 2 study of two dose levels","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116673","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116673"}}